click here for the university of warwick website click here for warwick ventures website
 
NEWS | CALENDAR | INVEST
back to top


Warwick Warp: wins Research Council's Business Plan Competition

warwick warp One of Warwick University's latest Spin-offs, Warwick Warp, was the all-out winner of the Research Council's Business Plan Competition, 2006. The RCUK Business Plan Competition provides support and training to develop high quality business plans to commercialise research carried out in UK universities and Public Service Research Establishments. The competition is supported by all 8 UK Research Councils and is open to researchers based in UK Higher Education Institutions (HEIís) or Public Sector Research Establishments (PSRE) from across the whole spectrum of academic research.
>> more >>

Concurrent Thinking Partners with Oxford Capital Partners

concurrent thinkingWarwick Spin-Out Concurrent Thinking (formerly Streamline Computing) is the UK's leading company in the High Performance and Technical Computing ('HPTC' or 'Supercomputing') market and has recently secured £1.5 million in funding. The round completed with an investor syndicate led by Oxford Capital Partners, introduced to the company last year at the Connect Midlands' Investment Conference (CMIC).

Dr Victor Christou, Investment Manager at Oxford Capital Partners, said 'Oxford Capital Partners has found Connect Midlands events to be a very useful way to uncover new investment opportunities with exceptional potential. We first saw our portfolio company, Concurrent Thinking, at the Connect Midlands' annual Investment Conference in 2005, followed up with a meeting after the event and subsequently made an investment. The conference in 2006 was equally interesting and we have already spoken to a number of companies who presented at that meeting as a result. I think that the Connect Midlands' network is a great way to meet exciting entrepreneurial businesses from the Midlands who are looking for funding.'

'Over the lifetime of the company, Concurrent Thinking has demonstrated exceptional growth while investing significantly in R&D. We welcome the new partnership with Oxford Capital Partners and the Forward Group, as well as the continued support of existing investors such as Midven, in helping us to achieve our ambitious goals' said Dr Michael Rudgyard, CEO and founder.



Lord Stafford Awards: Knowledge Transfer Champion

Warwick Ventures' Director, Ederyn Williams, was the proud recipient of the award for "Knowledge Transfer Champion" at this year's prestigious Lord Stafford Award ceremony. Each year awards are afforded to individuals, businesses, and organisations which are recognised as having stimulated innovative collaboration between West Midlands' businesses and Universities. Each year for the last 4 years, spin-outs from The University of Warwick and, now the Director of it's Technology Transfer Offices, have received one of its coveted awards and a cheque for the Department of £5,000.

Warwick's previous winners include:

- Dr. Ederyn Williams, (Winner 2006)
- Advancesis, (Winner 2005)
- Warwick Effect Polymers, (Winner 2004)
- Streamline, (now Concurrent Thinking) (Winner 2003)
- DigePrint, (Winner 2002)


Dr. Suzanne Evans joins Warwick Ventures

This month we welcome Dr. Suzanne Evans to our team. Suzanne read Microbiology at the University of Dundee and then undertook a PhD in anaerobic digestion (Essex). She has worked in the Cabinet Office in Whitehall, the Science and Engineering Research Council and managed research programmes for the DTI. For the past 11 years Suzanne has been working in environmental consultancy, specialising in business development, strategy and government policy work in the area of alternative energy.

Sarissa Biomedical Founder Honoured

Professor Nick Dale, founder of Warwick University spin-off, Sarissa Biomedical Ltd, and Head of Neurosciences Research Group in Biological Sciences, has been awarded one of only 10 highly prestigious Milstein Awards by the Medical Research Council (MRC) this year, for his innovative approach to investigating glucosensing in the brain. The MRC have created the awards to encourage innovative research; if Nick's work goes according to plan it might well lead to new therapeutic opportunities for treating obesity and its attendant major health complaints such as diabetes.
>>more >>






Warwick Research Excellence Portal to be Launched

During the spring term, the University of Warwick will be launching a new research portal called Warwick Research Excellence. The portal will showcase the research expertise and facilities available within the University of Warwick, seeking to aid communication with business locally, regionally and nationally. The aim is to provide a simple route for business to access the full range of what Warwick has to offer - including applied research, technology and knowledge development, expertise in continuing professional development, the licensing of intellectual property and consultancy. In addition, the portal aims to improve the experience of applying for a research degree at Warwick by allowing potential postgraduate students to access information on funding opportunities and to search for academic supervisors working within their area of interest.
>> more >>

NEWS | CALENDAR | INVEST
back to top

Month

Date

Event

Venue

Partner

March

Thu 22nd

Connect Midlands - Springboard

The Athena, Leicester

connect midlands
Connect Midland's Springboard event is a one-day platform that allows early-stage companies to present their innovations and showcase their ideas, concepts and proposals. This event calls upon entrepreneurs and inventors, looking for finance of up to £500k, to produce a ten-minute presentation to an invited audience of investors and business advisors.

NEWS | CALENDAR | INVEST
back to top

In this section we ask for your help in identifying potential partners or licensing opportunities for our spin-offs. Maybe you are interested in collaborating with one of our companies or maybe you know somebody else who is?

Virabiotech

  • A new technology for preventing the flu
  • Not a chemical (like Tamiflu) or a vaccine
  • Works against all the different strains, and should work against future pandemic strains
  • Animal work completed, two patents filed
  • Preliminary business plan available
  • Initial investment interest established
  • Needs to build the team
If you are keen to learn more about this young company at this important stage in their development please contact Dr. Ederyn Williams at our offices.

Sonemat

  • Unique expertise in material testing, arising from £s; millions of research funding with industry (Corus, BNFL, Rolls Royce)
  • Company currently trading and not yet seeking funding
  • Has technologies that could be further exploited
  • Would like to meet industry specialists willing to play an active role
If you are keen to learn more about this young company at this important stage in their development please contact Dr. John Mihell at our offices.
 
PARTNER PROGRAMMES
back to top
Our Partner, Connect Midlands
SMALL PRINT
back to top

    About Us
    Warwick Ventures is the technology transfer office at the University of Warwick. We exist to enhance the reputation of the University of Warwick, by demonstrating that the University makes good use of IP arising from publicly funded research, for the benefit of the academics, the University and the region and country as a whole; and to generate additional revenues from the exploitation of the research and expertise of the University, making a significant contribution to the finances of the University in the medium to long term.

    Subscribe / Unsubscribe If you would like to subscribe to this newsletter, please click here. Alternatively, if you would like to unsubscribe please click here.

    Privacy Policy We guarantee that we will not give the names or email addresses of subscribers to any third party unless required to do so by law.

    Editorial Press releases and other information can be sent to the editorial team at ventures@warwick.ac.uk

    Disclaimer The material set out here is provided for information purposes only. Warwick Ventures does not take any responsibility for the accuracy of the information provided. Before making any investment decision, potential investors should consult their own professional advisors.